Basit öğe kaydını göster

dc.contributor.authorTopcull, Mehmet Rıfkı
dc.contributor.authorCetin, Idil
dc.contributor.authorKarali, Nilgün Lütfiye
dc.contributor.authorElma, Pinar Eraslan
dc.date.accessioned2021-03-06T09:59:06Z
dc.date.available2021-03-06T09:59:06Z
dc.identifier.citationCetin I., Elma P. E. , Topcull M. R. , Karali N. L. , "Anticancer activities and cell death mechanisms of 1H-indole-2,3-dione 3-[N-(4 sulfamoylphenyl)thiosemicarbazone] derivatives", ISTANBUL JOURNAL OF PHARMACY, cilt.48, ss.63-67, 2018
dc.identifier.othervv_1032021
dc.identifier.otherav_e81652cb-fb98-4a3f-b4bf-43db8e435f9e
dc.identifier.urihttp://hdl.handle.net/20.500.12627/152588
dc.identifier.urihttps://doi.org/10.26650/istanbuljpharm.2018.414805
dc.description.abstractIn this study, the cytotoxic effects of 1H-indole-2,3-dione 3-[N-(4-sulfamoylphenyl)thiosemicarbazone derivatives namely, 4a-d were evaluated using cell kinetic parameters including the cell index, mitotic index, labelling index and apoptotic index on HeLa cells taken from a human cervix carcinoma. All compounds were evaluated using cell index parameters at 5, 10, 20, 40, 80, 100 and 160 mu M concentrations. As a result of this, it was seen that all 4a-d compounds were effective in different concentrations. Different cell death mechanisms were proposed for 4a-d. When all the parameters were examined, it was found that the bromine substituted 4c was the most potent antiproliferative compound in the tested compounds. The difference was significant between the control and experimental groups (p<0.01). In addition, a statistically significant difference was noted among all experimental groups (p<0.01).
dc.language.isoeng
dc.subjectYaşam Bilimleri
dc.subjectTemel Bilimler
dc.subjectEczacılık
dc.subjectTemel Eczacılık Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectFarmakoloji ve Toksikoloji
dc.subjectFARMAKOLOJİ VE ECZACILIK
dc.titleAnticancer activities and cell death mechanisms of 1H-indole-2,3-dione 3-[N-(4 sulfamoylphenyl)thiosemicarbazone] derivatives
dc.typeMakale
dc.relation.journalISTANBUL JOURNAL OF PHARMACY
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume48
dc.identifier.startpage63
dc.identifier.endpage67
dc.contributor.firstauthorID2360235


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster